SAVITRI
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

SAVITRI Trademark

Serial Number: 98211377

SAVITRI is a trademark filed by Neurocrine Biosciences, Inc. on October 5, 2023. The trademark is classified under Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

Neurocrine Biosciences, Inc. (237 trademarks)

6027 Edgewood Bend Court
San Diego, CA 92130

Entity Type: 03

Trademark Details

Filing Date

October 5, 2023

Registration Date

Not Registered

Published for Opposition

June 18, 2024

Goods & Services

Providing medical information; providing medical information relating to therapies and treatments for major depressive disorder and neurological, central nervous system, psychiatric, and mood disorders

Pharmaceutical research and development services; conducting clinical trials for others for pharmaceutical preparations; pharmaceutical research services and pharmaceutical product evaluation, namely, conducting post-authorization research for the marketing of pharmaceutical preparations and evaluating epidemiological results; pharmaceutical research and development services in the field of major depressive disorder and neurological, central nervous system, psychiatric, and mood disorders; conducting clinical trials for others for pharmaceutical preparations for the treatment and prevention of major depressive disorder and neurological, central nervous system, psychiatric, and mood disorders; pharmaceutical research services and pharmaceutical product evaluation, namely, conducting post-authorization research for the marketing of pharmaceutical preparations for the treatment and prevention of major depressive disorder and neurological, central nervous system, psychiatric, and mood disorders, and evaluating epidemiological results for treatments for major depressive disorder and neurological, central nervous system, psychiatric, and mood disorders; providing medical and scientific research information to patients and practitioners in the field of clinical trials, namely, as to the results of clinical trials; providing medical and scientific research information to patients and practitioners in the field of clinical trials, namely, as to the results of clinical trials pertaining to therapies and treatments for major depressive disorder and neurological, central nervous system, psychiatric, and mood disorders

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 28, 2026 EXRA
SOU EXTENSION 3 GRANTED
Jan 27, 2026 EX3G
SOU EXTENSION 3 FILED
Jan 27, 2026 EXT3
SOU TEAS EXTENSION RECEIVED
Jan 27, 2026 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 1, 2025 EXRA
SOU EXTENSION 2 GRANTED
Jul 30, 2025 EX2G
SOU EXTENSION 2 FILED
Jul 30, 2025 EXT2
SOU TEAS EXTENSION RECEIVED
Jul 30, 2025 EEXT
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 20, 2025 TCCA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Mar 20, 2025 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Mar 20, 2025 COAR
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 8, 2025 EXRA
SOU EXTENSION 1 GRANTED
Feb 8, 2025 EX1G
SOU EXTENSION 1 FILED
Feb 7, 2025 EXT1
SOU TEAS EXTENSION RECEIVED
Feb 7, 2025 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Aug 13, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 18, 2024 NPUB
PUBLISHED FOR OPPOSITION
Jun 18, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 29, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
May 16, 2024 CNSA
ASSIGNED TO EXAMINER
May 15, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 14, 2023 NWOS
NEW APPLICATION ENTERED
Oct 9, 2023 NWAP